Porphyromonas gingivalis Promotes Glioma Progression via the PI3K/AKT/mTOR Signaling Pathway
Cells · 31.10.2026 · 15 (21) · 1998
DOI: 10.3390/cells15211998 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 31.10.2026. Verfasst von Mengyao Leng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, China. Hauptthemen laut MEDLINE: Porphyromonas gingivalis, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioma is the most prevalent and aggressive brain tumor with high recurrence rates and poor survival. Porphyromonas gingivalis (P. gingivalis), a major periodontal pathogen, has emerged as a potential contributor to neurological diseases. However, whether P. gingivalis is present in glioma tissues and directly promotes malignant progression remains unclear. Here, immunohistochemistry the detected gingipain in 11 of 13 human glioma specimens, while fluorescence in situ hybridization further detected P. gingivalis-targeted 16S rRNA signals in 3 of 13 specimens. These findings support the presence of P. gingivalis-associated signals in human glioma tissues. In cellular models, P. gingivalis invaded glioblastoma cells and promoted cell proliferation, migration, and invasion through induction of mesenchymal transition and extracellular matrix remodeling, thereby accelerating glioma progression. In a mouse xenograft model, P. gingivalis inoculation enhanced tumor growth and was associated with changes in proliferation, mesenchymal transition, and ECM remodeling-related markers. Mechanistically, P. gingivalis activated the PI3K/AKT/mTOR signaling pathway, while pharmacological AKT inhibition (AKTi-1/2) effectively suppressed these tumor-promoting effects. Metronidazole treatment also reduced tumor growth in vivo. Collectively, these findings identify P. gingivalis as a potential microbial contributor to glioma malignant progression and support further investigation of host–microbe interactions and AKT signaling as potential avenues for therapeutic research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, China.
- Department of Neurosurgery, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, China.
ORCID-Profile: Zhiqiang Li, Bo Cheng
Zitieren
APA
Leng, M., Weng, X., Luo, J., Hou, C., Wang, S., Li, Z., & Cheng, B. (2026). Porphyromonas gingivalis Promotes Glioma Progression via the PI3K/AKT/mTOR Signaling Pathway. Cells, 15(21), 1998. https://doi.org/10.3390/cells15211998
Vancouver
Leng M, Weng X, Luo J, Hou C, Wang S, Li Z, et al. Porphyromonas gingivalis Promotes Glioma Progression via the PI3K/AKT/mTOR Signaling Pathway. Cells. 2026;15(21):1998. doi:10.3390/cells15211998
BibTeX
@article{Leng2026,
author = {Leng, Mengyao and Weng, Xiuhong and Luo, Jingyi and Hou, Chenxing and Wang, Simin and Li, Zhiqiang and Cheng, Bo},
title = {Porphyromonas gingivalis Promotes Glioma Progression via the PI3K/AKT/mTOR Signaling Pathway},
journal = {Cells},
year = {2026},
volume = {15},
number = {21},
pages = {1998},
doi = {10.3390/cells15211998}
}
EUVIMED